Image commercially licensed from Unsplash
Alcohol consumption has been a part of human history for centuries, often serving as a social lubricant, a means of celebration, and a way to unwind after a long day. However, with its consumption comes a potential downside – alcohol intoxication. The effects of excessive alcohol consumption not only impair an individual’s ability to function, but can also lead to severe consequences, including drunk driving accidents and alcohol-related incidents.
Thankfully, the landscape has the potential to change with the introduction of a groundbreaking solution: UNBUZZD™, a revolutionary functional beverage developed by FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a Life Sciences company committed to pioneering innovative biotech solutions for challenging neurodegenerative, inflammatory, and metabolic disorders.
A New Era: Science Meets Alcohol Metabolism
In 2023, FSD Pharma is aiming to redefine how society deals with the effects of alcohol consumption. Unlike conventional remedies that rely on time to sober up, UNBUZZD™ utilizes cutting-edge science to accelerate alcohol metabolism and provide rapid relief from inebriation. This is not just another hangover cure product; UNBUZZD™ is the future of combating alcohol intoxication.
Understanding UNBUZZD™ in a Nutshell
UNBUZZD™ represents a proprietary formulation of natural ingredients, vitamins, and minerals designed to enhance liver and brain function, helping individuals quickly recover from the effects of alcohol consumption. Through small focus group research, UNBUZZD™ has demonstrated the ability to reduce Breath Alcohol Concentration (BrAC) faster than the body’s natural processes. Clinical trials are planned to validate these findings further.
The active ingredients in UNBUZZD™’s formula act to restore mental alertness after alcohol consumption within an average of 30-60 minutes. The innovative approach of UNBUZZD™ goes beyond mere hangover relief, offering a powerful means to mitigate the burden of alcohol-induced impairment on society.
A Greater Purpose: Redefining the Paradigm
Today’s recovery drinks focus on relieving discomfort after a night of drinking, but UNBUZZD™ seeks to transcend this limited scope. The purpose of UNBUZZD™ is to reshape how society deals with the aftermath of excessive alcohol consumption and its far-reaching impact on countless lives.
Alcohol-related accidents and incidents continue to plague communities worldwide, and the statistics are sobering. According to Mothers Against Drunk Driving (MADD.ORG), 2 out of 3 people will be affected by drunk driving in their lifetime, and every 45 minutes, someone loses their life in a drunk driving crash. Moreover, the 2021 National Survey on Drug Use and Health (NSDUH) by the US Department of Health and Human Services revealed alarming figures, with 66.9% of people aged 18+ reporting alcohol consumption in the past year and 23.3% engaging in binge drinking in the past month.
The repercussions of excessive alcohol consumption are not limited to individuals alone; they have a ripple effect on healthcare resources, with inebriated individuals frequently ending up in hospital emergency rooms. Dr. Albert Wong, an FSD Pharma’s Expert Advisory Committee member, noted the substantial time and effort required to manage alcohol intoxication cases in emergency departments. An innovation like UNBUZZD™ could alleviate the burden on healthcare resources and offer additional treatment options for alcohol use disorders.
Science Behind Alcohol Metabolism
To understand how UNBUZZD™ works, it’s essential to comprehend how alcohol is metabolized in the body. When alcohol is consumed, it is broken down by alcohol dehydrogenase (ADH) into acetaldehyde, a toxic compound known for its adverse effects on the body. The liver then processes acetaldehyde to eliminate it from the system. However, this process takes time, leading to alcohol’s intoxicating effects.
The rate of alcohol metabolism varies depending on several factors, but on average, the body processes about one standard drink per hour for men. Numerous remedies have been proposed to expedite alcohol metabolism, but most have proven ineffective. Products like UNBUZZD™ represent a revolutionary advancement in this field, offering a scientific and validated approach to accelerate alcohol metabolism and reduce BrAC levels efficiently.
UNBUZZD™: The Path Ahead
The potential impact of UNBUZZD™ on society is undeniable. Its ability to accelerate recovery from alcohol intoxication and mitigate hangover severity could transform how we view alcohol consumption and its aftermath. This revolutionary functional beverage could promote responsible drinking, reducing the number of alcohol-related accidents and ultimately saving lives.
FSD Pharma’s dedication to research and development is evident in its impressive portfolio, which includes other groundbreaking assets like Lucid-MS, a patented neuroprotective compound for the treatment of neurodegenerative diseases, including Multiple Sclerosis. As the company advances its lead drug candidates through clinical trials, its vision of providing therapies to millions suffering from neurodegenerative and neuropsychiatric conditions is becoming a reality.
The future is undoubtedly exciting for FSD Pharma and UNBUZZD™. With a team of visionary experts, including renowned entrepreneurs like Kevin Harrington, John Duffy, and Gerry David, FSD Pharma is poised to make a significant societal impact through its innovative solutions. UNBUZZD™ is more than a functional beverage; it represents a beacon of hope, offering clarity and relief in an era where science meets the complexities of human health.
HUGE investors, consumers, and professionals alike are looking ahead to the upcoming commercialization of UNBUZZD™. To spearhead the launch, FSD Pharma recently partnered with Celly Nutrition, giving Celly exclusive rights to recreational applications for UNBUZZD™ and commercialization of the product. FSD Pharma has retained all other rights, notably applications for usage in emergency rooms and with first responders where the company sees a tremendous opportunity to fill a chasm in the market.
Leading the UNBUZZD™ launch will be ex-Coke VP of National Sales and new Celly CEO John Duffy. During 22+ years at Coca-Cola, Duffy shouldered countless responsibilities, including oversight for the customer management team of Sysco, Coke’s largest foodservice distributor.
David will be invaluable in the launch, recently appointed as Chairman of the Board at Celly. David is a legend in the beverage industry, turning around Nasdaq-listed fitness drink maker Celsius Holdings, resulting in an influx of capital from nameworthy investors and a 35x surge in market capitalization to over $9 billion.
As UNBUZZD™ sets a new standard for alcohol metabolism, it is likely to become an essential part of modern society’s toolkit for responsible and mindful drinking. As clinical trials further validate the product’s efficacy and safety, UNBUZZD™ could revolutionize the way we approach alcohol consumption and enhance the well-being of individuals and communities worldwide. So, ready to embrace a new era where science leads the way to a safer, more responsible drinking culture with UNBUZZD™.
